Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Ensuring consistent glycosylation‐associated quality of therapeutic monoclonal antibodies (mAbs) has become a priority in pharmaceutical bioprocessing given that the distribution and composition of the carbohydrates (glycans) bound to these molecules determines their therapeutic efficacy and immunogenicity. However, the interaction between bioprocess conditions, cellular metabolism and the intracellular process of glycosylation remains to be fully understood. To gain further insight into these interactions, we present a novel integrated modelling platform that links dynamic variations in mAb glycosylation with cellular secretory capacity. Two alternative mechanistic representations of how mAb specific productivity (qp) influences glycosylation are compared. In the first, mAb glycosylation is modulated by the linear velocity with which secretory cargo traverses the Golgi apparatus. In the second, glycosylation is influenced by variations in Golgi volume. Within our modelling framework, both mechanisms accurately reproduce experimentally‐observed dynamic changes in mAb glycosylation. In addition, an optimisation‐based strategy has been developed to estimate the concentration of glycosylation enzymes required to minimise mAb glycoform variability. Our results suggest that the availability of glycosylation machinery relative to cellular secretory capacity may play a crucial role in mAb glycosylation. In the future, the modelling framework presented here may aid in selecting and engineering cell lines that ensure consistent mAb glycosylatio.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829 · cited 3×
“All commercially‐ available mAbs contain two consensus asparagine‐linked (N‐linked) glycosylation sites on the Cγ2 domains of their constant fragment (Fc) [3].”
BackgroundMalhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B. (1995) · Nature Medicine · doi:10.1038/nm0395-237 · Cited by 786
Goetze, A. M., Liu, Y. D., Zhang, Z., Shah, B., Lee, E., Bondarenko, P. V., & Flynn, G. C. (2011) · Glycobiology · doi:10.1093/glycob/cwr027 · Cited by 467 · cited 1×
“The Man5 glycoform has been associated with decreased serum half‐life [14, 15] and compromised effector function activation of mAbs [3, 16].”
BackgroundControl of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro
Hodoniczky, J., Zheng, Y. Z., & James, D. C. (2005) · Biotechnology Progress · doi:10.1021/bp050228w · Cited by 393 · cited 1×
“Reduced galactosylation, in turn, has been associated with decreased complement activation [18].”
BackgroundModulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
Gramer, M. J., Eckblad, J. J., Donahue, R., Brown, J., Shultz, C., Vickerman, K., Priem, P., van den Bremer, E. T. J., Gerritsen, J., & van Berkel, P. H. C. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23075 · Cited by 193
Tigges, M., & Fussenegger, M. (2006) · Metabolic Engineering · doi:10.1016/j.ymben.2006.01.006 · Cited by 178 · cited 4×
“CS2: Increased could also arise from an enlarged secretory (Golgi) apparatus [29, 30].”
BackgroundResultInfluentialA mathematical model of N-linked glycosylation
Krambeck, F. J., & Betenbaugh, M. J. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20645 · Cited by 171 · cited 2×
“Of these, the models formulated by Umaña and Bailey [24], Krambeck and Betenbaugh [19], Hossler et al. [20] and del Val et al. [21] are single‐cell models where glycosylation is assumed to be independent of extracellular conditions, cell growth and recombinant protein productivity.”
MethodJimenez del Val, I., Nagy, J. M., & Kontoravdi, C. (2011) · Biotechnology Progress · doi:10.1002/btpr.688 · Cited by 135 · cited 7×
“[21] are single‐cell models where glycosylation is assumed to be independent of extracellular conditions, cell growth and recombinant protein productivity.”
BackgroundMethodResultInfluentialDu, Z., Treiber, D., McCarter, J. D., Fomina‐Yadlin, D., Saleem, R. A., McCoy, R. E., Zhang, Y., Tharmalingam, T., Leith, M., Follstad, B. D., et al. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25332 · Cited by 113
Cited by
Model-based optimization of antibody galactosylation in CHO cell culture
Kotidis, P., Jedrzejewski, P., Sou, S. N., Sellick, C., Polizzi, K., del Val, I. J., & Kontoravdi, C. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26960 · Cited by 90
Sou, S. N., Jedrzejewski, P. M., Lee, K., Sellick, C., Polizzi, K. M., & Kontoravdi, C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26225 · Cited by 45
“The effect of increased Golgi volume on enzyme concentration is also taken into account, by assuming that the increase in Golgi volume is proportional to the increase in qmab (Jimenez del Val et al., 2016).”
BackgroundMadabhushi, S. R., Podtelezhnikov, A. A., Murgolo, N., Xu, S., & Lin, H. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.01.023 · Cited by 27
mAb Production Modeling and Design Space Evaluation Including Glycosylation Process
Yang, O., & Ierapetritou, M. (2021) · Processes · doi:10.3390/pr9020324 · Cited by 26
“The above settings are used as inputs for our kinetic model simulation, wherein the operating procedures and designs are based on the cited papers [21,24].”
BackgroundMethodComputational tools for predicting and controlling the glycosylation of biopharmaceuticals
Kontoravdi, C., & Jimenez del Val, I. (2018) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2018.08.007 · Cited by 18
Self-citation
Metadata
- Authors
- Jimenez del Val, I., Fan, Y., & Weilguny, D.
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2016-02-12
- Volume
- 11
- Issue
- 5
- Pages
- 610-623
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2222857812
- Cited by
- 62
- References
- 12
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework. https://app.cochat.ai/papers/10.1002/biot.201400663
- The paper
- Jimenez del Val, I., Fan, Y., & Weilguny, D. (2016). Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework. Biotechnology Journal. https://doi.org/10.1002/biot.201400663
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.